Earnings Call · Q2 FY2021·2021-08-13

Q2 21EPS -10.20%·Rev n/aQ1 21EPS +30.07%·Rev n/aQ4 20EPS -100.00%*·Rev n/aQ3 20EPS -29.73%·Rev n/a⚠ consensus missing

Dare Bioscience, Inc. DARE

Sabrina Martucci Johnson — Chief Executive Officer

John Fair — Chief Commercial Officer

Lisa Walters-Hoffert — Chief Financial Officer

−5.9%1d on move date−6.1% vs SPY3d−12.9%5d−13.5%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more DARE calls or request research access.

More DARE calls Browse calls Request research access